Lauren Anthony, MD, FCAP, discusses gene panels for detecting mutations that lead to targeted therapies for patients with cancer. "Getting consensus and standardization and establishing high-reliability processes around these labor-intensive manual send-outs is a challenge, and there’s an increasing desire for and use of the largest possible gene panels," said Dr. Anthony.
For the full article click here: In-house or send-out? Lab approaches to gene panels